bpc 157 for hashimoto's The Stable Gastric Pentadecapeptide Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity 510K#: K190054

BPC-157 is a synthetic peptide derived from a naturally occurring protein found in the gastric system. It's been widely studied in preclinical models for its role in supporting the body's healing processes

TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days

510K#: K190054

Choose Your Bundle:2 Pack | 4oz size

When deficient, animals can have reduced appetite and growth rates, ill thrift, infertility, and reduced wool and milk production